Company / Accounts Receivable
Bio Essence Corp Accounts Receivable History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$23.5K
FY2025
5-year range
$5.1K / $35.1K
FY2021-FY2025
Trend
+357.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable changed +358% YoY in FY2025, a notable deviation from the 4-year average annual change of +183%.
Based on SEC 10-K filings.
$23,454 in FY2025 with a 3-year CAGR of +61.2%.
Declined from $35,093 to $23,454 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +61.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +61.2%, indicating consistent growth.
- In FY2025, accounts receivable increased 357.7% year-over-year.
- Peak accounts receivable was recorded in FY2023.
- Lowest accounts receivable in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 9/9 (strong financial health signals)
- Altman Z-Score -11.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.5K | +357.7% |
| FY2024 | $5.1K | -85.4% |
| FY2023 | $35.1K | +526.8% |
| FY2022 | $5.6K | -66.7% |
| FY2021 | $16.8K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 29, 2026